×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北京... [5]
中南大学 [2]
上海中医药大学 [2]
昆明动物研究所 [2]
西安交通大学 [1]
四川大学 [1]
更多...
内容类型
期刊论文 [14]
会议论文 [3]
学位论文 [1]
发表日期
2018 [1]
2017 [2]
2016 [2]
2015 [7]
2014 [3]
2010 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共18条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study
会议论文
60th Annual Meeting of the American-Society-of-Hematology (ASH), DEC 01-04, 2018
作者:
Angelucci, Emanuele
;
Li, Junmin
;
Greenberg, Peter L.
;
Depei, Wu
;
Hou, Ming
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/31
Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro
期刊论文
LEUKEMIA RESEARCH, 2017, 卷号: 62
作者:
Xu, Ming
;
Ren, Jian-ye
;
Guo, Yuan-cheng
;
Xu, Bai-xue
;
Zeng, Qing
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Myelodysplastic syndromes (MDS)
Arsenic disulfide (As2S2)
Histone acetylation1 (HDAC1)
Toll like receptor 2 (TLR2)
Erythroid transcription factor (GATA-1)
Apoptosis
Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro
期刊论文
Leukemia research, 2017, 卷号: 62, 页码: 4-11
作者:
Xu Ming[1]
;
Ren Jian-Ye[2]
;
Guo Yuan-Cheng[3]
;
Xu Bai-Xue[4]
;
Zeng Qing[5]
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/04/26
Apoptosis
Arsenic disulfide (As(2)S(2))
Erythroid transcription factor (GATA-1)
Histone acetylation1 (HDAC1)
Myelodysplastic syndromes (MDS)
Toll like receptor 2 (TLR2)
Apoptosis in human myelodysplastic syndrome CD34+cells is modulated by the upregulation of TLRs and histone H4 acetylation via a beta-arrestin 1 dependent mechanism
期刊论文
EXPERIMENTAL CELL RESEARCH, 2016, 卷号: 340, 期号: 1
作者:
Zeng, Qing
;
Shu, Jing
;
Hu, Qi
;
Zhou, Shao-Hong
;
Qian, Yi-Ming
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Myelodysplastic syndromes (MDS)
Apoptosis Histone acetylation
Toll-like receptor
beta-arrestin 1
The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China
期刊论文
ANNALS OF HEMATOLOGY, 2016, 卷号: 95, 期号: 8
作者:
Hu, Qinyong
;
Chu, Yuxin
;
Song, Qibin
;
Yao, Yi
;
Yang, Weihong
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
Myelodysplastic syndrome (MDS)
Prevalence
Chromosomal aberration
Genechip
Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study.
期刊论文
Advances in therapy, 2015, 卷号: 32, 期号: [db:dc_citation_issue], 页码: 1140-59
作者:
Wu Depei
;
Du Xin
;
Jin Jie
;
Xiao Zhijian
;
Shen Zhixiang
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/02
Myelodysplastic syndrome (MDS)
Oncology
Phase 3b
Hematology
Chinese population
Decitabine
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
期刊论文
Journal of Hematology & Oncology, 2015, 卷号: 8, 期号: 1, 页码: 45
作者:
Ok, Chi Young
;
Patel, Keyur P
;
Garcia-Manero, Guillermo
;
Routbort, Mark J
;
Peng, Jie
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/03
TP53
Therapy-related
MDS
AML
Karyotype
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases
期刊论文
Leukemia Research, 2015, 卷号: 39, 期号: 3, 页码: 348-354
作者:
Ok, Chi Young
;
Patel, Keyur P.
;
Garcia-Manero, Guillermo
;
Routbort, Mark J.
;
Fu, Bin
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/03
Next generation sequencing
Therapy-related
MDS
AML
Karyotype
TP53
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes
期刊论文
2015, 卷号: 5, 页码: 12
作者:
Feng Gege
;
Gale Robert Peter
;
Cui Wen
;
Cai Wenyu
;
Huang Gang
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/04
Dysplastic megakaryocytes
Immunochemistry
MDS
Prognosis
PHARMACOKINETICS (PK) OF SUBCUTANEOUS (SC) AZACITIDINE (AZA) IN CHINESE SUBJECTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) FROMA PHASE II, OPEN-LABEL STUDY.
会议论文
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015-02-01
作者:
Laille, E.
;
Xiao, Z.
;
Du, X.
;
Dong, Q.
;
Songer, S.
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2020/01/13
©版权所有 ©2017 CSpace - Powered by
CSpace